Contract pharmaceutical services supplier Arch Pharmalabs has
purchased a 70 per cent stake in fellow India-based active
pharmaceutical supplier (API) Benzochem Lifesciences for around Rs
1bn ($23m), strengthening its position in...
The new European Chemicals Agency (ECHA) opened its doors in
Helsinki this week, with questions raised immediately about its
ability to handle the thousands of registration requests required
under the controversial REACH legislation.
Archimedes Development, a subsidiary of Archimedes Pharma, expects
that the intellectual property it has licensed from fellow UK firm
Ploughshare Innovations will help extend the application of its
ChiSys drug delivery system.
The European Union's 2007 pharmaceutical counterfeiting data shows
that almost 40 per cent of fake medicines seized by the EU
originated in Switzerland.
Tongjitang Chinese Medicines, which produces traditional
treatments, has stopped manufacturing operations at its facility in
Guiyang, Guizhou province due to damage caused by the recent
earthquake.
The opening of ORF Genetics' $1m production site for recombinant
proteins in Grindavik, Iceland, is yet another groundbreaking move
by this year's winner of the Icelandic Centre for Research's
innovation award.
Switzerland-based Schweizerhall appears to have circumnavigated
patent law, with approval of its generic version of Bristol-Myers
Squibb's (BSM) and Sanofi-Aventis' Plavix (clopidogrel bisulfate)
in Germany "expected...
China is on course to having its own version of the International
Pharmaceutical Excipients Council - joining its fellow
organisations in Europe, the Americas and Japan.
Cambrex has experienced a jump in profitability for the first
quarter 2008, despite a decrease in sales, assisted by previous
cost-cutting initiatives.
Teva's sales of active pharmaceutical ingredients (APIs) for the
first quarter of 2008 rose by 51 per cent on the previous years
figure, taking to total to $510m.
Swedish authorities have recalled Sanofi Aventis' low molecular
weight injectable blood thinner Lovenox (enoxaparin), known locally
as Klexane, after four batches of the blockbuster drug were found
to contain oversulfated chondroitin...
Dutch chemical group DSM has acquired Polymer Technology Group
(PTG) and predicted its best financial year to date following
organic sales growth of 14 per cent for the first quarter.
US drugmaker Unigene has begun construction of new facilities in
China as part of its joint venture with a state-owned Chinese
pharmaceutical company to establish research, development and
manufacturing capacities in the nation.
The US Food and Drug Administration (FDA) has revealed it will be
operating on the ground in China imminently, while the Drug
Information Association (DIA) has just planted itself in Asia's
other pharma don, India.
GEA Pharma Systems' Collette unit will present Consigma, its new
continuous high shear granulation and drying system, at the
Interpack exhibition in Düsseldorf later this month.
Eli Lilly plans to cut 500 jobs, mainly in manufacturing, as it
attempts to restructure its operations to mitigate against the
losses from inhaled insulin.
The US Food and Drug Administration (FDA) believes that the
contamination of Baxter's blood thinner heparin, which has been
linked to 62 deaths in the US, may have been due to the deliberate
replacement of some ingredients with...
Pharmaceutical firms operating in Canada could face increasing
regulatory pressure if government plans to tighten up consumer
protection laws are passed.
The number of people whose deaths are associated with an allergic
reaction to heparin has shot up as the US Food and Drug
Administration (FDA) has updated its tally.
Actavis has purchased a 90 per cent stake in Zhejiang Chiral
Medicine Chemicals (CMC), a Hangzhou, China-based active
pharmaceutical ingredients (API) maker.
Stiefel Laboratories, Biopharm Services, Multisorb Technologies,
the Pharmaceutical Research and Manufacturers of America, Catalent
Pharma Solutions and Chromatide have all had people on the
move in the world of pharmaceutical manufacturing.
India's Jubilant Organosys has made good on promises to make
acquisitions in the contract research and manufacturing services
(CRAMS) sector with a $255m deal to buy Draxis Health of Canada.
The pharmacopoeias of the US and China will work more closely
together in future in a bid to improve the quality of medicines
available in both countries.
Denmark's Novozymes has signed an exclusive worldwide licensing
agreement with CSL Behring for albufuse, a proprietary albumin
fusion technology that can extend the circulatory half-life of
therapeutic proteins through genetic...
New research has shown that the FDA's strict 10-month deadline for
a drug's approval following submission may compromise drug safety
and lead to insufficient data for precise drug administration.
Canada's SemBioSys Genetics has begun final pre-clinical studies of
its novel plant-produced insulin product in preparation for its
submission to US regulatory authorities.
Redpoint Bio has been issued with a patent for an assay technology
which tests whether a compound enhances or inhibits the bitter or
sweet taste of different ingredients, allowing the company to
screen for flavour enchancing compounds.
The generic pharmaceutical industry has given short shrift to the
latest congressional attempt to construct a viable approval pathway
for biosimilars in the US.
The pharmaceutical industry has lost confidence in the UK as a
place to do business to an "alarming degree" and the
situation is only set to deteriorate, reveals new research.
French group Rhodia has put its gradual retreat from a flagging
fine chemicals business on a more formal footing by announcing the
break-up of Rhodia Organics.
Cambrex Corp, the US-based manufacturer of small-molecule active
pharmaceutical ingredients (APIs) and advanced intermediates for
the drug industry, has announced that one of its customers is
recalling a product for which Cambrex...
Switzerland's Siegfried Holding says that a significant jump in
2007 net profit, up 54 per cent to CHF 49.7m ($50m), vindicates its
decision to refocus on the active pharmaceutical ingredients and
generics sector.
A revised glycerin monograph has been announced at the US
Pharmacopeial (USP) Convention which it is hoped will further
decrease the likelihood of health hazards associated with
diethylene glycol-contaminated glycerin.
The costs of introducing any formal good manufacturing practice
(GMP) requirements for potentially high-risk pharmaceutical
excipients in the European Union would far exceed the likely
benefits, concludes an impact assessment for...
Drug delivery specialist Eurand could see a marked increase in
revenue flow this year, both from co-development products
incorporating the company's formulation technologies and a
proprietary treatment addressing the estimated...
Scientists have provoked a soil-dwelling bacteria into producing a
potent antibiotic by pitting it against another bacteria, despite
the fact that previously it had never been known to produce such
products.
Dissolved charged particles frequently form the waste product of
both industrial and biological processes, but while it has been
easy to remove positive ions (cations) without disturbing the
surrounding solution, it has been significantly...
German chemicals giant BASF has announced its latest brace of price
rises, this time for two forms of carboxylic acid and for bleaching
and reducing agents.
With active pharmaceutical ingredient sales of $1,460m (€960.8m) in
2007 and a portfolio of more than 250 compounds, Teva
Pharmaceutical Industries is by a long stretch the dominant
supplier in the global API market.
A long-acting injectable formulation of Eli Lilly's blockbuster
schizophrenia treatment Zyprexa (olanzapine), with the potential to
improve patient adherence and take some of the sting out of generic
competition three years down...
Jubilant Organosys, India's largest custom research and
manufacturing services (CRAMS) provider, has scored new contracts
to the tune of $92m for the year thus far as its business continues
to gather momentum.